Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Cheifetz, A. S.
401  Ergebnisse:
Personensuche X
?
1

Mo1101 Systematic Analysis of the Quality Underlying the Sc..:

Feuerstein, Joseph D. ; Akbari, Mona ; Leffler, Daniel A...
Gastroenterology.  144 (2013)  5 - p. S-578 , 2013
Link: https://doi.org/10.1016/..
 
?
2

DOP45 Adequate infliximab exposure during the induction pha..:

Vande Casteele, N ; Papamichael, K ; Jeyarajah, J..
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S053-S054 , 2019
Link: https://doi.org/10.1093/..
 
?
3

Emergency department utilisation for inflammatory bowel dis..:

Ballou, S. ; Hirsch, W. ; Singh, P....
Alimentary Pharmacology & Therapeutics.  47 (2018)  7 - p. 913-921 , 2018
Link: https://doi.org/10.1111/..
 
?
4

Letter: infliximab concentrations during induction therapy—..:

Papamichael, K. ; Cheifetz, A. S.
Alimentary Pharmacology & Therapeutics.  47 (2018)  9 - p. 1334-1335 , 2018
Link: https://doi.org/10.1111/..
 
?
5

Editorial: early post‐induction anti‐TNF drug monitoring ca..:

Papamichael, K. ; Cheifetz, A. S.
Alimentary Pharmacology & Therapeutics.  47 (2018)  3 - p. 436-437 , 2018
Link: https://doi.org/10.1111/..
 
?
6

Editorial: therapeutic de‐escalation of anti‐tumour necrosi..:

Papamichael, K. ; Cheifetz, A. S.
Alimentary Pharmacology & Therapeutics.  45 (2017)  9 - p. 1265-1266 , 2017
Link: https://doi.org/10.1111/..
 
?
7

Infliximab trough concentrations during maintenance therapy..:

Papamichael, K. ; Rakowsky, S. ; Rivera, C...
Alimentary Pharmacology & Therapeutics.  47 (2017)  4 - p. 478-484 , 2017
Link: https://doi.org/10.1111/..
 
?
8

A rare case series of concomitant inflammatory bowel diseas..:

Feuerstein, J.D. ; Flier, S.N. ; Yee, E.U...
Journal of Crohn's and Colitis.  8 (2014)  12 - p. 1735-1739 , 2014
Link: https://doi.org/10.1016/..
 
?
9

P151 Recommendations for creating a high quality endoscopy ..:

Devlin, S.M. ; Melmed, G.Y. ; Irving, P.M....
Journal of Crohn's and Colitis.  8 (2014)  - p. S125 , 2014
Link: https://doi.org/10.1016/..
 
?
10

The use of pharmacological prophylaxis against venous throm..:

Pleet, J. L. ; Vaughn, B. P. ; Morris, J. A...
Alimentary Pharmacology & Therapeutics.  39 (2014)  9 - p. 940-948 , 2014
Link: https://doi.org/10.1111/..
 
?
11

The Crohn's disease activity index (CDAI) is similarly elev..:

Lahiff, C. ; Safaie, P. ; Awais, A....
Alimentary Pharmacology & Therapeutics.  37 (2013)  8 - p. 786-794 , 2013
Link: https://doi.org/10.1111/..
 
?
12

Letter: international IBD practice guidelines - authors' re..:

Feuerstein, J. D. ; Leffler, D. A. ; Cheifetz, A. S.
Alimentary Pharmacology & Therapeutics.  38 (2013)  3 - p. 326-327 , 2013
Link: https://doi.org/10.1111/..
 
?
13

Systematic review: the quality of the scientific evidence a..:

Feuerstein, J. D. ; Akbari, M. ; Gifford, A. E....
Alimentary Pharmacology & Therapeutics.  37 (2013)  10 - p. 937-946 , 2013
Link: https://doi.org/10.1111/..
 
?
14

Letter: inflammatory bowel disease guidelines and conflicts..:

Feuerstein, J. D. ; Leffler, D. A. ; Cheifetz, A. S.
Alimentary Pharmacology & Therapeutics.  38 (2013)  4 - p. 445-446 , 2013
Link: https://doi.org/10.1111/..
 
?
15

Commentary: irritable bowel syndrome and the CDAI – mislead..:

Lahiff, C. ; Cheifetz, A. S.
Alimentary Pharmacology & Therapeutics.  37 (2013)  10 - p. 1021-1022 , 2013
Link: https://doi.org/10.1111/..
 
1-15